C-265 (45-1) - An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
This bill creates a pre-approved list of unapproved therapeutic products that doctors can access more easily for patients with serious or life-threatening conditions.
1st Reading
Mar 19, 2026